Chembond Material Technologies Ltd

To,

The Members,

Your Directors take pleasure in presenting the 50^th Annual Report on the business and operations of your Company together with the audited financial statements for the year ended March 31,2025.

The financial performance of your Company is as summarized below:

During the year under review, consolidated revenue from operations was Rs 20,129.99 lakhs as compared to Rs 17,824.43 lakhs in the previous year. On a standalone basis, your Company's revenues from operations were Rs 17,120.70 lakhs as compared to Rs 15,334.04 lakhs in the previous year.

Consolidated profit before tax for the current year was Rs 1,946.10 lakhs as against Rs 1,669.47 lakhs in the previous year. On a standalone basis, your Company's profit before tax for the current year was Rs 1,919.05 lakhs as against Rs 1,942.87 lakhs in the previous year.

Consolidated profit after tax for the current year was Rs 1,756.24 lakhs as against Rs 1,117.63 lakhs in the previous year. On a standalone basis, your Company's profit after tax for the current year was Rs 1,722.36 lakhs as against Rs 1,382.45 lakhs in the previous year.

The Board of Directors of the Company at its meeting held on December 12, 2023 approved the Composite Scheme of Arrangement between Chembond Material Technologies Limited (formerly Chembond Chemicals Limited) (“Demerged Company”/ “Transferee Company”/”CMTL”) and Chembond Chemical Specialties Limited (“Resulting Company”/”CCL”) and Chembond Clean Water Technologies Limited (“Transferor Company No. 1” or “CCWTL”) and Chembond Material Technologies Private Limited (“Transferor Company No. 2” or “CMTPL”) and Phiroze Sethna Private Limited (“Transferor Company No. 3” or “PSPL”) and Gramos Chemicals (India) Private Limited (“Transferor Company no. 4” or “GCIPL”) and their respective shareholders under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (“the Act”).

The Scheme envisaged transfer of Construction Chemical and Water Treatment (“CC & WT”) business to Chembond Chemical Specialties Limited - Resulting Company by way of demerger and post demerger, amalgamation of CCWTL with Resulting Company (Amalgamation I) and amalgamation of CMTPL, PSPL and GCIPL with Demerged Company (Amalgamation II). The National Company Law Tribunal (NCLT) has approved the Scheme vide its order dated April 7, 2025 and the Scheme has become effective from Saturday, May 03, 2025.

Pursuant to Clause 42 of the Composite Scheme of Arrangement, the name of the Company has changed from ‘Chembond Chemicals Limited' to ‘Chembond Material Technologies Limited' with effect from May 27, 2025.

After the approval of the Composite Scheme of Arrangement the Company continues to engage in manufacturing specialty chemicals like high performance coatings, automotive sealants, metal treatment chemicals, engineering adhesives, and animal health and industrial biotech products.

The Board of Directors have recommended final dividend of Rs1.75 (Rupee One and Paisa Seventy Five only) per share (35%) for the financial year ended March 31,2025.

In view of the changes made under the Income-Tax Act, 1961, by the Finance Act, 2020, dividends paid or distributed by the Company shall be taxable in the hands of the Shareholders. Your Company shall, accordingly, make the payment of the final Dividend after deduction of tax at source.

In accordance with Regulation 43A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations”), the Board of Directors of the Company has voluntarily adopted a Dividend Distribution Policy (“Policy”) which endeavors for fairness, consistency and sustainability while distributing profits to the shareholders. Dividend payout is in accordance with the Policy which is available on the website of the Company i.e. https://chembond.in/all-policies/.

The movement of Paid-up Equity Capital is as under:

During the year 2024-25, there was no change in the Paid-up capital of the Company.

Pursuant to the Composite Scheme of Arrangement the Authorised Share Capital of the Company increased w.e.f. the appointed date i.e. April 1,2024 as given below:

Your Company has only one class of Equity Shares and it has neither issued shares with differential rights for dividend, voting or otherwise, nor issued shares (including sweat equity shares) to the employees or Directors of the Company, under any Scheme.

No disclosure is required under Section 67(3)(c) of the Act in respect of voting rights not exercised directly by the employees or Key Managerial Personnel of the Company as the provisions of the Section are not applicable.

The Company has not accepted any deposits within the meaning of Section 73 of the Act read with the Companies (Acceptance of Deposits) Rules, 2014 as amended from time to time.

The Board of Directors has decided to retain the entire amount of profits for FY 2024-25 in the retained earnings. (Previous year Nil)

The Company recognizes the importance of a diverse Board in the growth and success of the organization. It is also crucial for effective corporate governance and improved organizational performance. It helps enhance decision-making, fostering a wider range of perspectives, leading to better understanding of stakeholders and improved risk management. Diversity also boosts innovation, reflects the diversity of the company's stakeholders, and can positively impact financial performance and reputation.

As on the date of this report, the Board of the Company consists of six Directors comprising of one Nonexecutive Non-Independent Director, two Executive Directors, and three Independent Directors, of whom one is a Woman. The Chairman of the Board is an Executive Director.

In accordance with the provisions of Section 152(6) of the Act, Mr. Nirmal V. Shah (DIN:00083853) Nonexecutive Director, retires by rotation and being eligible, offers himself for re-appointment. His background is given in the Notice, which forms part of Annual Report.

Based on the recommendation of Nomination and Remuneration Committee (NRC) and in accordance with the provisions of the Act and the Listing Regulations, the Company appointed Mr. Mayank P. Shah (DIN:01655046) and Mrs. Gorsi A. Parekh (DIN:00343194) as Additional (Non-executive and Independent) Directors of the Company for a period of five (5) years w.e.f. March 22, 2025 till March 21, 2030 and shareholders' approval of the same was accorded through Postal Ballot on May 27, 2025.

Based on the recommendation of the NRC, Mr. Jaywant K. Tawade (DIN:08231649) was appointed as an Additional (Executive) Director of the Company for a period of three (3) years, w.e.f. May 31, 2025 subject to approval of the Members of the Company in the ensuing General Meeting.

After the date of the Board's Report, based on the recommendations of the NRC, Mr. Kamal Tandon (DIN:09664746) was appointed as an Additional (Independent) Director of the Company for a period of five years (5) w.e.f. July 16, 2025 till July 15, 2030 subject to approval of the Members of the Company in the ensuing General Meeting.

Mr. Mahendra Ghelani (DIN:01108297) and Mr. Sushil Lakhani (DIN:01578957) ceased to be Independent Directors of the Company on August 8, 2024 upon completion of their second consecutive term of appointment.

Mrs. Saraswati Sankar (DIN:07133249) ceased to be an Independent Director of the Company on March 23, 2025 upon completion of her second consecutive term of appointment.

Dr. Prakash Trivedi (DIN:00231288) ceased to be an Independent Director of the Company on May 20, 2025 upon completion of his second consecutive term of appointment.

Mr. Ashwin R. Nagarwadia (DIN:00466681), a Nonexecutive Director stepped down from his position as a Director of the Company due to advancing age and associated concerns about being able to contribute to the Board in the future with the same energy with effect from May 30, 2025.

Mr. Nirmal V. Shah (DIN:00083853) stepped down from the position of Vice-Chairman and Managing Director, w.e.f. May 30, 2025 due to the fact that he will be CMD of the resulting company, Chembond Chemical Specialties Limited. Mr. Nirmal V. Shah shall continue as a Non-executive Director of the Company.

The Board acknowledges and expresses its heartfelt gratitude for the exceptional contributions made by Mr. Mahendra Ghelani, Mr. Sushil Lakhani, Mrs. Saraswati Sankar, Dr. Prakash Trivedi, and Mr. Ashwin Nagarwadia during their association with the Company.

Mr. Sameer V. Shah (DIN:00105721) was re-appointed as the Chairman & Managing Director of the Company based on the recommendation of the NRC and the Board of Directors at its meeting held on May 30, 2025 for a period of three years w.e.f. August 1, 2025 to July 31,2028 subject to approval of Members at the ensuing General Meeting.

Mr. Sameer V. Shah, Chairman & Managing Director and Mr. Nirmal V. Shah, Non-executive Director are relatives (siblings). Apart from this none of the Directors of the Company are in any way related to each other.

All the Independent Directors of the Company have furnished a declaration to the effect that they meet the criteria of independence as provided in Section 149(6) of the Act and Regulations 16(1)(b) and 25 of the Listing Regulations. In the opinion of the Board, all the Independent Directors possess the integrity, expertise and experience including the proficiency required to be Independent Directors of the Company, fulfil the conditions of independence as specified in the Act and the Listing Regulations and are independent of the management and have also complied with the Code for Independent Directors as prescribed in Schedule IV of the Act.

Further declaration of independence as required under the Listing Regulations were also given by the Directors.

The Company has put in place an appropriate policy on appointment and remuneration of Directors and other matters provided under Section 178(3) of the Act. This policy is uploaded on the Company's website https://chembond.in/all-policies/. Salient features of the policy on remuneration of Directors have been disclosed in the Notice of this Annual Report.

Pursuant to the provisions of Section 203 of the Act, Mr. Sameer V. Shah, Chairman & Managing Director, Mrs. Rashmi Gavli, Chief Financial Officer and Mrs. Suchita Singh, Company Secretary are the Key Managerial Personnel of the Company as on the date of this Report.

Five (5) meetings of the Board were held during the year under review, details of which are furnished in the Corporate Governance Report forming part of the Annual Report. The maximum gap between two Board Meetings did not exceed 120 days, as prescribed under the Act.

The Board of Directors have carried out an evaluation of its own performance and that of its Committees and of the individual Directors for the year pursuant to the provisions of the Act and Corporate Governance requirements as prescribed by the Listing Regulations.

The performance of the Board and its Committees was evaluated by the Board after seeking inputs from the Board / Committee Members based on criteria such as composition of the Board / Committees and structure, effectiveness of the Board / Committee processes, providing of information and functioning etc. The Board and the NRC reviewed the performance of individual Directors based on criteria such as attendance in Board / Committee meetings, contribution in the meetings like preparedness on issues to be discussed etc.

The Independent Directors at its separate meeting held on February 20, 2025, reviewed the performance of Non-Independent Directors and performance of the Board as a whole, performance of the Chairman of the Company taking into account the views of Executive and Non-executive Directors and assessed the quality, quantity and timeliness of flow of information to the Board to perform their duties effectively and reasonably.

Pursuant to Section 134(5) of the Act, the Board of Directors, to the best of their knowledge and ability, in respect of the year ended March 31,2025, confirm that:

(a) in the preparation of the annual accounts, the applicable accounting standards have been followed and that there are no material departures;

(b) they have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for that period;

(c) they took proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

(d) they prepared the annual accounts on a going concern basis;

(e) they laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and were operating effectively; and

(f) they devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

The details in respect of role/powers/composition of the Audit Committee and other information are included in the Corporate Governance Report forming part of this Annual Report.

M/s. Bathiya & Associates, LLP, Chartered Accountants (FRN:101046W/W100063) name changed to S H B A & CO LLP with effect from December 17, 2024 were appointed for second term as the Statutory Auditor of the Company for a period of five (5) consecutive years at the 48^th Annual General Meeting (AGM) held on August 19, 2023 until the conclusion of the 53^rd AGM to be held in FY 2028. However, the Auditors have expressed their intention to resign as Statutory Auditor of Company from the date of the ensuing 50^th AGM vide their letter dated May 27, 2025 placed before the Audit Committee and Board at its meeting held on May 30, 2025, following the completion of the statutory audit for the financial year ended March 31, 2025 and the limited review for the quarter ending June 30, 2025 in view of the restructuring in the Company pursuant to Composite Scheme of Arrangement and their continuation as Statutory Auditors of the resulting company viz. Chembond Chemical Specialties Limited.

The Board at its meeting held on May 30, 2025 based on the recommendation of Audit Committee have recommended appointment of M/s. Kastury & Talati, Chartered Accountants (Firm Reg. No. 104908W) as Statutory Auditor of the Company from the date of ensuing 50^th AGM for a term of five (5) years i.e. till the 55^th AGM to be held in the year 2030, subject to approval of the shareholders.

The Report given by the Auditors on the financial statements of the Company is part of this Report. There has been no modified opinion, qualification, reservation, adverse remark or disclaimer given by the Auditors in their Report during the year under review and the observations and comments given in the report of the Statutory Auditors read together with Notes to Accounts are self-explanatory and hence do not call for any further explanation or comments under Section 134 (f)(i) of the Act.

As per the requirement of Central Government and pursuant to Section 148 of the Act read with the Companies (Cost Records and Audit) Rules, 2014 as amended from time to time, your Company has been carrying out audit of cost records every year.

The Board of Directors on the recommendation of Audit Committee, at their meeting held on May 30, 2025 appointed M/s. Aatish & Associates, Cost & Management Accountants, Mumbai, (FRN: 006726/Membership No. 30105) as the Cost Auditor to conduct audit of the cost records of the Company for FY 2025-26. The Company is seeking the approval of the Shareholders for the remuneration to be paid to M/s. Aatish & Associates, Cost & Management Accountant for the FY ending March 31,2026.

M/s. Aatish & Associates have confirmed that they are free from disqualification specified under Section 141(3) and proviso to Section 148(3) read with Section 141(4) of the Act and that the appointment meets the requirements of Section 141(3)(g) of the Act. They have further confirmed their independent status and an arm's length relationship with the Company.

The relevant Cost Audit Report for the FY 2023-24 was filed with Ministry of Corporate Affairs on August 30, 2024 in Form CRA-4.

Pursuant to the provisions of Section 204 of the Act, the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, and Regulation 24A of the Listing Regulations, Board of Directors of the Company has recommended appointment of Mr. Virendra G. Bhatt, Practicing Company Secretary (C.P. No.: 124) to undertake the Secretarial Audit of the Company for the period of five (5) years from FY 202526 till FY 2029-30 subject to approval of shareholders at the ensuing General Meeting at such remuneration as shall be fixed by the Board of Directors of the Company. The Company has received their written consent and confirmation that the appointment will be in accordance with the applicable provisions of the Act and rules framed thereunder.

The Secretarial Audit Report in Form MR- 3 for the Financial Year ended March 31,2025 has been annexed as Annexure 1.

There are no qualification, reservation, adverse remark or disclaimer given by the Secretarial auditor in their report for the year under review.

During the year under review, the Statutory Auditor, Cost Auditor and Secretarial Auditor have not reported any instances of frauds committed in the Company by its officers or employees, to the Audit Committee under Section 143(12) of the Act details of which needs to be mentioned in this Annual Report.

Your Company has one subsidiary company namely Chembond Biosciences Limited.

The details of financial performance of the subsidiary are given in AOC-I as Annexure 2.

Further, pursuant to the provisions of Section 136 of the Act, the standalone financial statements of the Company, consolidated financial statements along with relevant documents and separate audited financial statements in respect of subsidiary, are available on the Company's website https://chembond.in/subsidiary-financials/.

Pursuant to the effectiveness of the Composite Scheme of Arrangement approved by The Hon'ble National CompanyLawTribunal, Mumbai Bench, Court Ivideorder C.P.(CAA)/23(MB)2025 C/W C.A.(CAA)/162(MB)2024 on April 7, 2025 the following Companies have ceased to be subsidiaries of the Company.

i. Chembond Chemical Specialties Limited (CCSL)

ii. Chembond Calvatis Industrial Hygiene Systems Limited

iii. Chembond Clean Water Technologies Limited (merged with CCSL w.e.f. May 3, 2025)

iv. Chembond Distribution Limited

v. Chembond Material Technologies Private Limited (merged with CMTL w.e.f. May 3, 2025)

vi. Chembond Water Technologies Limited

vii. Chembond Water Technologies (Malaysia) Sdn. Bhd.

viii. Chembond Water Technologies (Thailand) Co. Ltd.

ix. Phiroze Sethna Private Limited (merged with CMTL

w.e.f. May 3, 2025)

x. Gramos Chemicals India Private Limited (merged with CMTL w.e.f. May 3, 2025)

The said Scheme was implemented with the objective of restructuring and streamlining the group's operations for better strategic alignment and operational efficiency. Consequently, the above-mentioned companies have been transferred or reorganized in accordance with the terms of the Scheme and applicable regulatory approvals.

The information required under Section 197(12) of the Act read with Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, as amended, is given in Annexure 3.

The statement containing particulars of employees as required under Section 197 of the Act read with Rule 5(2) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, as amended, will be provided upon request to the Company. None of the employees of the Company are being paid remuneration exceeding the prescribed limit under the said provisions and Rules.

During the FY 2024-25, Mr. Sameer V. Shah - Chairman & Managing Director received remuneration of Rs 37.13 lakhs from Chembond Biosciences Limited, WOS Company.

No commission was paid to the Non-executive Directors for FY 2024-25.

In terms of the provisions of the Act and the Listing Regulations, the Company has adopted all the applicable policies. The policies are available on the website of the Company at https://chembond.in/all-policies/. All Directors and Senior Management Personnel have affirmed their adherence to the provisions of the Code of Conduct during the FY 2024-25. The Company's policy on Directors' appointment, remuneration and other matters provided in Section 178(3) of the Act forms part of Nomination and Remuneration Policy and has been disclosed in the Corporate Governance Report.

As per the requirements of the Listing Regulations, a Risk Management Committee was constituted with the responsibility of preparation of a Risk Management

Plan, reviewing and monitoring the same on regular basis, to identify and review critical risks on regular basis, to report key changes in critical risks to the Board on an on-going basis, to report critical risks to the Audit Committee in detail on a yearly basis and such other functions as may be prescribed by the Board. The Company has its Risk Management Plan & Policy in place which is also displayed on the website of the Company i.e. https://chembond.in/all-policies/. In the opinion of the Board, during the FY 2024-25, no elements of risk which may threaten the existence of the Company were noticed by the Board. The Committee monitors the risk management plan and ensures its effectiveness. The details of Committee are set out in the Corporate Governance Report.

The Board is responsible for establishing and maintaining adequate internal financial control as per Section 134 of the Act.

Your Company has in place an adequate system of internal controls to ensure compliance with various policies, practices and statutes. The Company maintains robust internal financial controls systems and processes that are commensurate with the size, nature, geographical spread and complexities of its operation both at entity and process levels of the Company. Management exercises financial control on the operations through standard operating procedures covering all financial and operating functions which is designed to provide a reasonable assurance with regards to maintaining of proper accounting controls for ensuring reliability of financial reporting, effectiveness and efficiency of operations, safeguarding assets from unauthorized use or losses and compliance with applicable laws and regulations. Key controls have been tested during the year and corrective and preventive actions has been taken for any weakness. During the year no frauds were detected or reported to the Audit Committee.

A separate Corporate Governance Report on compliance with Corporate Governance requirements as required under Regulation 34(3) read with Schedule V of the Listing Regulations forms part of this Annual Report. The same has been reviewed and certified by Mr. Virendra G. Bhatt, Practicing Company Secretary, the Secretarial Auditor of the Company and Compliance Certificate in respect thereof is attached as Annexure 4.

The Company has formulated a Whistle Blower Policy, details of which are furnished in the Corporate Governance Report, thereby establishing a vigil mechanism for Directors and permanent employees for reporting genuine concerns or grievances, if any, about unethical behaviour, actual or suspected fraud or violation of Company's Code of Conduct or policies. It also provides adequate safeguards against the victimization of employees and allows direct access to the chairperson of Audit Committee in appropriate or exceptional cases. The vigil mechanism / whistle blower policy is available on Company's website https://chembond.in/all-policies/.

Pursuant to Section 135 of the Act read with the Companies (Corporate Social Responsibility Policy) Rules, 2014 as amended from time to time, the Board of Directors of the Company has duly constituted the Corporate Social Responsibility (CSR) Committee, adopted CSR policy and spent amount on CSR activities in accordance with the Act, applicable to your Company.

The Company reviews and revises its CSR Policy pursuant to the Companies (Corporate Social Responsibility) Amendment Rules, 2021 from time to time. The CSR policy is available on Company's website at https://chembond.in/all-policies/.

The key philosophy of all CSR initiatives of the Company is guided by three core commitments of Scale, Impact and Sustainability. For other details regarding the CSR Committee, please refer to the Corporate Governance Report, which is part of this Annual report.

During the year, the Company has spent Rs 18.60 lakhs on CSR activities through Visan Trust. The Company has identified focus areas of engagement which have been enumerated in the Annual Report on CSR Activities attached as Annexure 5.

All transactions entered into with related parties during the financial year were in the ordinary course of business and on arm's length basis and do not attract the provisions of Section 188(1) of the Act. Accordingly, the prescribed form AOC-2 is not applicable to your Company for FY 2025 and hence, does not form part of this report. Suitable disclosures as required by the Indian Accounting Standards (Ind AS-24) have been made in the notes to the Financial Statements. The Board has a policy for related party transactions which has been uploaded on the Company's website https://chembond.in/all-policies/.

The particulars relating to conservation of energy, technology absorption and foreign exchange earnings and outgo, as required to be disclosed under Section 134(3)(m) of the Act read with Rule 8(3) of the Companies (Account) Rules, 2014, as amended from time to time, are provided in Annexure 6.

Details of loans, guarantees and investments have been disclosed in the Financial Statements.

The Promoter & Promoter Group's holding in the Company as on March 31, 2025 was 67.65% of the Paid-up Equity Capital. The members may note that the shareholding and other details of Promoters has been provided in the Annual Return.

The Annual Return as provided under Section 92(3) read with Section 134(3)(a) of the Act as prescribed in Form No. MGT-7 of the Companies (Management and Administration) Rules, 2014, is available on the website of the company at https://chembond.in/annual-reports/.

Management Discussion and Analysis Report for the year under review, as stipulated under the Listing Regulations, is presented in a separate section, forming part of this Annual Report.

Members are requested to note that all unpaid / unclaimed dividends for a period of seven consecutive years from the date of transfer to the Company's Unpaid Dividend Account, shall be transferred by the Company to the Investor Education and Protection Fund (IEPF Fund) established by the Central Government. Further, pursuant to the provisions of Section 124 of the Act read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended from time to time, all shares on which dividend has not been paid or claimed for seven consecutive years or more shall be transferred to IEPF Authority as notified by the Ministry of Corporate Affairs.

The Company has transferred shares to the demat account of the IEPF authority in respect of which dividend has not been claimed for seven consecutive years or more. It had communicated to all the concerned shareholders individually whose shares were liable to be transferred to IEPF. The Company had also given newspaper advertisements, before such transfer in favour of IEPF and also uploaded the details of such shareholders and shares transferred on the website of the Company.

The Members/Claimants whose shares and unclaimed dividend amount have been transferred to IEPF may claim the shares or apply for refund by making an application to IEPF Authority in Form IEPF-5 (available on www.iepf.gov.in). The Member/Claimant can file only one consolidated claim in a Financial Year as per the IEPF Rules.

The Company has in place an Anti-Sexual Harassment Policy in line with the requirements of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013. The policy for Prevention of Sexual Harassment at workplace is available on the website of the Company https:// chembond.in/all-policies/. Internal Complaints Committee (ICC) has been set up to redress complaints received regarding sexual harassment. All employees (permanent, contractual, temporary and trainees) are covered under this policy. They are also provided training about the Act. During the year under review, no complaint was received.

The Business Responsibility and Sustainability Report for the year ended March 31, 2025 as stipulated under Regulation 34 of the Listing Regulations is not applicable to the Company.

Except as disclosed elsewhere in the Report, there have been no material changes and commitment affecting, the financial position of your Company, which have occurred between the end of the financial year of the Company and the date of this Report.

During the year under review, there has been one pending litigation against the Company and its Directors whose order is yet to be received. The matter is explained in detail in the Corporate Governance Section of the Annual Report. Except this there has been no significant and material order passed by the Regulators or Courts or Tribunals impacting the going concern status of the Company and its future operations.

There are no such proceedings or appeals pending and no applications has been filed under Insolvency and Bankruptcy Code, 2016 during the year under review and from the end of the financial year upto the date of this report.

No such instance of One-time settlement or valuation was done while taking or discharging loan from the Banks/ Financial Institutions occurred during the year.

In terms of Section 118(10) of the Act, the Company is complying with the Secretarial Standards issued by the Institute of Company Secretaries of India (ICSI) with respect to Meetings of Board of Directors and General Meetings and such systems were adequate and operating effectively.

The Company recognizes the need to have well equipped R&D facilities to meet customer requirements and in developing cutting edge products. As a natural corollary your Company continues to invest in a comprehensive Research and Development programme leveraging its world-class infrastructure, benchmarked processes, state-of-the-art technology and a business-focused R&D strategy.

The Company has spent approx. Rs 73.86/- Lakhs during the year under report on research and development.

Your Board wish to place on record their appreciation and acknowledge with gratitude the support and cooperation extended by the Government authorities, Bankers, customers, vendors, employees and members during the year under review and look forward to their continued support.